C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/47 (2006.01) A61K 39/00 (2006.01) C07K 14/705 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2759425
The invention provides a peptide comprising a human cytolytic T lymphocyte (CTL) epitope from the human tumor-associated antigen (TAA) New Gene Expressed in Prostate (NGEP), which can be used in vaccine prevention or therapy of prostate cancer, as well as a nucleic acid encoding the peptide, a vector comprising the nucleic acid, a cell comprising the peptide, nucleic acid, or vector, and compositions thereof.
L'invention porte sur un peptide comprenant un épitope de lymphocyte T cytolytique (CTL) humain provenant de l'antigène humain associé aux tumeurs (TAA), le nouveau gène exprimé dans la prostate (NGEP), qui peut être utilisé dans la prévention par un vaccin ou la thérapie du cancer de la prostate, ainsi que sur un acide nucléique codant pour le peptide, un vecteur comprenant l'acide nucléique, une cellule comprenant le peptide, un acide nucléique ou un vecteur, et des compositions de ceux-ci.
Pastan Ira
Schlom Jeffrey
Tsang Kwong-Yok
Departmen T. Of Health And Human Services The United States Of America As Represented By The Secretary
Ridout & Maybee Llp
LandOfFree
Immunogenic epitopes of ngep antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic epitopes of ngep antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic epitopes of ngep antigen will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1509806